Brief: Incannex Healthcare Completes Positive Pre-Ind Meeting With Us FDA On Ihl-216A For Treatment Of Concussion And Traumatic Brain Injury
11/10/2022 13:06
Oct 11 (Reuters) - Incannex Healthcare Ltd IHL.AX :
* INCANNEX COMPLETES POSITIVE PRE-IND MEETING WITH US FDA ON
IHL-216A FOR TREATMENT OF CONCUSSION AND TRAUMATIC BRAIN INJURY
* INCANNEX HEALTHCARE LTD- IS DRAFTING A FOLLOW-UP REQUEST
FOR
ADDITIONAL INFORMATION ON FDA'S RECOMMENDATIONS
Source text for Eikon: ID:nGNX24TfdP
Further company coverage: IHL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed